TrialBritish journal of cancer2019

Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.

Naohiro Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.